We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CBT market cap is 4.6B. The company's latest EPS is USD 7.0083 and P/E is 12.10.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 958M | 1.02B | 1.02B | 1B | 955M |
| Operating Income | 136M | 156M | 172M | 150M | 155M |
| Net Income | 50M | 84M | 109M | 137M | 93M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.61B | 3.41B | 4.32B | 3.93B | 3.99B |
| Operating Income | 151M | 454M | 572M | 529M | 614M |
| Net Income | -238M | 250M | 209M | 445M | 380M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.7B | 3.6B | 3.58B | 3.74B | 3.64B |
| Total Liabilities | 2.22B | 2.09B | 2.08B | 2.15B | 2.13B |
| Total Equity | 1.48B | 1.51B | 1.5B | 1.59B | 1.52B |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.78B | 3.31B | 3.53B | 3.6B | 3.74B |
| Total Liabilities | 1.97B | 2.22B | 2.49B | 2.2B | 2.15B |
| Total Equity | 814M | 1.09B | 1.03B | 1.41B | 1.59B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 105M | 281M | 488M | 692M | 124M |
| Investing | -54M | -95M | -146M | -235M | -104M |
| Financing | -29M | -195M | -326M | -415M | -24M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 377M | 257M | 100M | 595M | 692M |
| Investing | -288M | -186M | -118M | -214M | -235M |
| Financing | -132M | -60M | 145M | -403M | -415M |
| Market Cap | 4.6B |
| Price to Earnings Ratio | 12.10 |
| Price to Sales Ratio | 1.15 |
| Price to Cash Ratio | 20.63 |
| Price to Book Ratio | 2.89 |
| Dividend Yield | 2.03% |
| Shares Outstanding | 54.22M |
| Average Volume (1 week) | 487.05k |
| Average Volume (1 Month) | 475.52k |
| 52 Week Change | -1.85% |
| 52 Week High | 117.46 |
| 52 Week Low | 79.57 |
| Spread (Intraday) | 19.1 (21.54%) |
| Company Name | Cabot Corp |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.cabotcorp.com |
| Industry | misc chemical products (2890) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
